Search

Your search keyword '"Flynn, Barbara J."' showing total 123 results

Search Constraints

Start Over You searched for: Author "Flynn, Barbara J." Remove constraint Author: "Flynn, Barbara J."
123 results on '"Flynn, Barbara J."'

Search Results

1. Variant-proof high affinity ACE2 antagonist limits SARS-CoV-2 replication in upper and lower airways

2. Cytotoxicity of human antibodies targeting the circumsporozoite protein is amplified by 3D substrate and correlates with protection

3. Innate immune activation restricts priming and protective efficacy of the radiation-attenuated PfSPZ malaria vaccine

4. Durable immunity to SARS-CoV-2 in both lower and upper airways achieved with a gorilla adenovirus (GRAd) S-2P vaccine in non-human primates

5. Mucosal Adenoviral-vectored Vaccine Boosting Durably Prevents XBB.1.16 Infection in Nonhuman Primates

6. Investigation of the impact of clonal hematopoiesis on severity and pathophysiology of COVID-19 in rhesus macaques

7. Attenuated PfSPZ Vaccine induces strain-transcending T cells and durable protection against heterologous controlled human malaria infection

8. RBD-based high affinity ACE2 antagonist limits SARS-CoV-2 replication in upper and lower airways

9. A human monoclonal antibody prevents malaria infection by targeting a new site of vulnerability on the parasite

10. Low-Dose Subcutaneous or Intravenous Monoclonal Antibody to Prevent Malaria

11. Author Correction: A human monoclonal antibody prevents malaria infection by targeting a new site of vulnerability on the parasite

12. mRNA-1273 or mRNA-Omicron boost in vaccinated macaques elicits similar B cell expansion, neutralizing responses, and protection from Omicron

13. mRNA-1273 or mRNA-Omicron boost in vaccinated macaques elicits comparable B cell expansion, neutralizing antibodies and protection against Omicron

14. The light chain of the L9 antibody is critical for binding circumsporozoite protein minor repeats and preventing malaria

15. Protection from SARS-CoV-2 Delta one year after mRNA-1273 vaccination in rhesus macaques coincides with anamnestic antibody response in the lung

17. Vaccination in a humanized mouse model elicits highly protective PfCSP-targeting anti-malarial antibodies

18. Protection from SARS-CoV-2 Delta one year after mRNA-1273 vaccination in nonhuman primates is coincident with an anamnestic antibody response in the lower airway

19. Innate immune activation restricts priming and protective efficacy of the radiation-attenuated PfSPZ malaria vaccine

20. A Monoclonal Antibody for Malaria Prevention

21. Protective antibodies elicited by SARS-CoV-2 spike protein vaccination are boosted in the lung after challenge in nonhuman primates

22. The light chain of the L9 antibody is critical for binding circumsporozoite protein minor repeats and preventing malaria

23. Functional human IgA targets a conserved site on malaria sporozoites

24. Protective T cell immunity in mice following protein-TLR7/8 agonist-conjugate immunization requires aggregation, type I IFN, and multiple DC subsets

25. Design of Alphavirus Virus-Like Particles Presenting Circumsporozoite Junctional Epitopes That Elicit Protection against Malaria

26. Vaccination with SARS-CoV-2 Spike Protein and AS03 Adjuvant Induces Rapid Anamnestic Antibodies in the Lung and Protects Against Virus Challenge in Nonhuman Primates

28. HIV Gag protein conjugated to a Toll-like receptor 7/8 agonist improves the magnitude and quality of Th1 and CD8+ T cell responses in nonhuman primates

29. Antibody Feedback Limits the Expansion of B Cell Responses to Malaria Vaccination but Drives Diversification of the Humoral Response

30. A Potent Anti-Malarial Human Monoclonal Antibody Targets Circumsporozoite Protein Minor Repeats and Neutralizes Sporozoites in the Liver

31. Antibody feedback limits the expansion of cognate memory B cells but drives the diversification of vaccine-induced antibody responses

32. Star nanoparticles delivering HIV-1 peptide minimal immunogens elicit near-native envelope antibody responses in nonhuman primates

33. Author Correction: A human monoclonal antibody prevents malaria infection by targeting a new site of vulnerability on the parasite

34. Innate transcriptional effects by adjuvants on the magnitude, quality, and durability of HIV envelope responses in NHPs

35. NSF Factbook. Guide to National Science Foundation Programs and Activities.

36. Coadministration of Polyinosinic:Polycytidylic Acid and Immunostimulatory Complexes Modifies Antigen Processing in Dendritic Cell Subsets and Enhances HIV Gag-Specific T Cell Immunity

37. Parasite-dependent cytotoxicity of human antibodies targeting the circumsporozoite protein is amplified by 3D-substrate and correlates with protection

38. Poly(I:C) is an effective adjuvant for antibody and multi-functional CD4+ T cell responses to Plasmodium falciparum circumsporozoite protein (CSP) and αDEC-CSP in non human primates

39. Toll-like receptor agonists influence the magnitude and quality of memory T cell responses after prime-boost immunization in nonhuman primates

42. Prime-Boost Vaccination with HIV-1 Gag Protein and Cytosine Phosphate Guanosine Oligodeoxynucleotide, Followed by Adenovirus, Induces Sustained and Robust Humoral and Cellular Immune Responses

44. Multifunctional TH1 cells define a correlate of vaccine-mediated protection against Leishmania major.

46. Analysis of immunoglobulin transcripts and hypermutation following SHIVAD8 infection and protein-plus-adjuvant immunization.

47. Durable immunity to SARS-CoV-2 in both lower and upper airways achieved with a gorilla adenovirus (GRAd) S-2P vaccine in non-human primates.

48. Mucosal Adenoviral-vectored Vaccine Boosting Durably Prevents XBB.1.16 Infection in Nonhuman Primates.

49. RBD-based high affinity ACE2 antagonist limits SARS-CoV-2 replication in upper and lower airways.

50. Investigation of the Impact of Clonal Hematopoiesis on Severity and Pathophysiology of COVID-19 in Rhesus Macaques.

Catalog

Books, media, physical & digital resources